Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Reducing the risks of nuclear war—the role of health professionals141
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance136
Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistance132
Correction to: Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis126
Platelet activation: a barrier to effective antitumor immunity79
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy78
Characteristics and developmental trajectory of clinical trials focused on tumor-infiltrating lymphocytes for cancer treatment70
Small extracellular vesicle TGF-β in cancer progression and immune evasion67
Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma65
Application of CAR-T therapy in solid tumors: current opportunities and challenges60
P38 kinase in gastrointestinal cancers54
Ending nuclear weapons, before they end us48
Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X48
Role of non-coding RNAs in neuroblastoma47
Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer45
Pan-cancer oncogenic properties and therapeutic potential of SF3B445
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis42
Unveiling the role of the extracellular matrix in the osteosarcoma tumor microenvironment through integrated transcriptomics and experimental validation38
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy37
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma37
NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis36
Self-replicating messenger RNA based cancer immunotherapy36
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 135
TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells34
circXRCC5 foster gastric cancer growth and metastasis by the HNRNPC/circXRCC5/miR-655-3p/RREB1/UBA2 positive feedback loop31
TRPM8 promotes hepatocellular carcinoma progression by inducing SNORA55 mediated nuclear-mitochondrial communication31
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c31
BCL-xL dependency in chromophobe renal cell carcinoma30
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)30
Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability30
0.14511704444885